Patents applications published 28 July 2010
Selected patent applications from the weekly European Patents Bulletin
- Embedding antibiotic compounds in solid polymers
Research Foundation of the City University of New York; Pace University; Long Island University; Innocenti, Gary 2209369*
- Compsns and methods for treatment of diabetic retinopathy
Sarcode Corp 2209371*
- Novel azetidinones useful as inhibitors of elastane
Merck Sharp &_Dohme 2209372*
- N-substituted oxindoline derivatives as calcium channel blocker
Merck Sharp &_Dohme 2209373*
- Tubulysins and processes for preparing
Endocyte 2209374*
- PARP_inhibitor compounds, compsns and methods of use
Eisai 2208375*
- Novel SEH_inhibitors and their use
GlaxoSmithKline 2209376*
- Use of vitamin D_receptor agonists and precursors to treat fibrosis
The Salk Institute for Biological Studies; University of Sydney 2209377*
- Method to sue compsns having antidepressant anxiolytic and other neuronal activity and compsns of matter
Triton Biopharma 2209380*
- Methods and compsns for treating post-operative pain comprising clonidine
Warsaw Orthopaedic; Medtronic 2209466*
- Multipart capsule for staged release of one or more substances
Glaxo Group 2209467*
- Sustained release chitosan capsules comprising chitosan and phytic acid
Industry-Academic Cooperation Foundation 2209468*
- Beta adrenergic receptor agonists for treatment of pain and/or inflammation
Warsaw Orthopaedic 2209469*
- Pharmaceutical compsn comprising peroxided oil and cholesterol and uses thereof in medical field
Carratelli, Mauro 2209470*
- Lipoxin A4 protection for cornea endothelial cells
The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College 2209471*
- Use of nitric acid to enhance the efficacy of silver and other topical wound care agents
The University of North Carolina at Chapel Hill 2209472*
- Method of treating polycystic kidney diseases with ceramide derivatives
Genzyme Corp 2209473*
- Broad spectrum beta-lactamase inhibitors
Sopharmia 2209474*
- Process for producing a monophasic pharmaceutical product for limiting/reducing the risk of deep vein thrombosis united with oral contraception
Bayer Schering Pharma 2209475*
- Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerisation domain-2 agonists for the treatment or prevention of toll-like receptor-4 associated disorders
University of Pittsburgh of the Commonwealth System of Higher Education 2209476*
- Olive oil formulation for pain relief
Kimberley-Clarke Worldwide 2209477*
- Condensation products based on bicyclic or polycyclic aromatic or heteroaromatic compounds
BASF 2209478*
- Mixed metal compounds for treatment of hyperphos phataemia
Ineos Healthcare 2209479*
- Combination therapy with organic arsenicals
Ziopharm Oncology 2209480*
- Use of microvesicles (MVs)_for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method
Fresenius Medical Care Deutschland 2209481*
- Skeletal muscle augmentation utilising muscle-derived progenitor compounds, and treatments thereof
University of Pittsburgh - of the Commonwealth System of Higher Education 2209482*
- Blood pressure lowering combination comprising IPP_and/or VPP
DSM_IP 2209483*
- Combination products for treating cancer
Institut National de la Sante et de la Recherche Medicale (INSERM); Cayla 2209484*
- Extracellular histones as biomarkers for prognosis and molecular targets for therapy
Oklahoma Medical Research Foundation 2209485*
- A method of treating cachexia with the removal or inactivation of macrophage inhibitory cytokine-1
St Vincent’s Hospital Sydney 2209486*
- Human factor IX_variants with an extended half life
The University of North Carolina at Chapel Hill; Inspiration Biopharmaceuticals 2209487*
- FGF9-related methods for treating anxiety
The Board of Trustees of the Leland Stanford Junior University 2209488*
- Live attenuated mycoplasma strains
Wyeth LLC 2209489*
- Antibody production elicited by a DNA vaccine delivered by electroporation
VGX_Pharmaceuticals 2209490*
- Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6)
Novartis 2209491*
- Methods of treating cancer using anti-CD24 antibodies
The Medical Research, Infrastructure and Health Services of the Tel Aviv Medical Centre 2209492*
- Compsns comprising sphingosine 1 phosphate (S1P) receptor modulators
Novartis 2209493*
- Novel conjugated proteins and peptides
Polytherics 2209494*
- TAZ/WWTR1 for diagnosis and treatment of cancer
Agency for Science, Technology and Research (A*Star) 2209495*
- Multifunctional degradable nanoparticles with control of size and functionalities
Vanderbilt University 2209496*
- Method of differentially diagnosing by SPECT different types of dementia
Philips Intellectual Property and Standards 2209497*
- Treatment of proliferative disorders using antibodies to PSMA
Cornell University 2209498*
- Apparatus and process for treating an aqueous solution containing biological contaminants
Molycorp Minerals 2209499*